Aaron S D, Angel J B, Lunau M, Wright K, Fex C, Le Saux N, Dales R E
Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Am J Respir Crit Care Med. 2001 Feb;163(2):349-55. doi: 10.1164/ajrccm.163.2.2003122.
There is increasing evidence that chronic obstructive pulmonary disease (COPD) is associated with chronic inflammation in the airways and lung parenchyma; however, little is known about the inflammatory response during acute COPD exacerbation. The objectives of this study were (1) to determine if inflammatory markers associated with neutrophilic inflammation and activation increase at times of acute COPD exacerbation relative to the clinically stable state, and (2) to determine whether the presence of acute bacterial or viral infection at the time of COPD exacerbation could be correlated with increases in sputum markers of inflammation. Induced sputum was collected from patients with COPD when they were clinically stable, during the time of an acute exacerbation, and 1 mo later. Sputum was analyzed at each time point for soluble markers associated with neutrophilic inflammation; myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-alpha), and interleukin-8 (IL-8). Serologic assays on acute and convalescent sera were performed for respiratory viruses, and induced sputum was also subject to quantitative bacterial cultures, viral cultures, and polymerase chain reaction (PCR) for detection of respiratory viruses. Fourteen of the 50 patients enrolled in the study met predetermined criteria for an acute COPD exacerbation over the 15-mo study period. TNF-alpha and IL-8 were significantly elevated in the sputum of patients during acute COPD exacerbation compared with when they were clinically stable (p = 0.01 and p = 0.05, respectively). Concentrations of these cytokines declined significantly 1 mo after the exacerbation. Three of 14 patients (21%) had confirmed bacterial or viral respiratory tract infections. Patients with documented infection did not demonstrate greater increases in sputum levels of inflammatory cytokines during exacerbations compared with patients without demonstrable infection. We conclude that markers of airway neutrophilic inflammation increase at the time of acute COPD exacerbation and then decline 1 mo later, and that this acute inflammatory response appears to occur independently of a demonstrable viral or bacterial airway infection.
越来越多的证据表明,慢性阻塞性肺疾病(COPD)与气道和肺实质的慢性炎症相关;然而,对于COPD急性加重期的炎症反应却知之甚少。本研究的目的是:(1)确定与中性粒细胞炎症和激活相关的炎症标志物在COPD急性加重期相对于临床稳定状态时是否增加;(2)确定COPD加重期急性细菌或病毒感染的存在是否与痰液炎症标志物的增加相关。在COPD患者临床稳定时、急性加重期以及1个月后采集诱导痰。在每个时间点分析痰液中与中性粒细胞炎症相关的可溶性标志物;髓过氧化物酶(MPO)、肿瘤坏死因子-α(TNF-α)和白细胞介素-8(IL-8)。对急性和恢复期血清进行呼吸道病毒的血清学检测,诱导痰也进行定量细菌培养、病毒培养以及用于检测呼吸道病毒的聚合酶链反应(PCR)。在15个月的研究期间,纳入研究的50例患者中有14例符合COPD急性加重的预定标准。与临床稳定时相比,COPD急性加重期患者痰液中的TNF-α和IL-8显著升高(分别为p = 0.01和p = 0.05)。这些细胞因子的浓度在加重期1个月后显著下降。14例患者中有3例(21%)确诊为细菌或病毒呼吸道感染。与无明显感染的患者相比,有记录感染的患者在加重期痰液中炎症细胞因子水平的升高并不更明显。我们得出结论,气道中性粒细胞炎症标志物在COPD急性加重期升高,然后在1个月后下降,并且这种急性炎症反应似乎独立于明显的病毒或细菌气道感染而发生。